Lifeway Foods Posts 37% Sales Surge on Kefir Demand, Expands Margins
Event summary
- Q1 2026 net sales hit $63.0M, up 37% YoY, driven by flagship kefir products
- Gross profit margin expanded 360 basis points to 27.5%
- Net income grew 32% to $4.7M, marking 26 consecutive quarters of growth
- Company launched strategic partnerships with Erewhon and hosted wellness events
- Reiterated $45–$50M Adjusted EBITDA target for FY 2027
The big picture
Lifeway's results reflect the accelerating consumer shift toward functional, protein-rich foods. The company's ability to expand margins while investing in innovation positions it well against competitors in the fermented dairy space. With $63M in quarterly sales, Lifeway is now testing whether it can maintain this momentum amid potential commodity price volatility.
What we're watching
- Demand Sustainability
- Whether GLP-1 user demand for probiotic foods will continue fueling growth
- Innovation Pace
- How quickly Muscle Mates™ and Kefir Butter™ can scale as category drivers
- Operational Leverage
- The effectiveness of SG&A investments in driving long-term profitability
